Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource, 1 online resource.
Sprache
Englisch

Erschienen in
Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers ; day:6 ; month:6 ; year:2023 ; pages:1-9
Journal of cardiovascular translational research ; (6.6.2023), 1-9

Urheber
Jansen, Mark
Schmidt, A. F.
Jans, J. J. M.
Christiaans, I.
Crabben, S. N. van der
Hoedemaekers, Y. M.
Dooijes, D.
Jongbloed, J. D. H.
Boven, L. G.
Lekanne Deprez, R. H.
Wilde, A. A. M.
Velden, J. van der
Boer, R. A. de
Tintelen, J. P. van
Asselbergs, F. W.
Baas, A. F.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s12265-023-10398-2
URN
urn:nbn:de:101:1-2023091516163178414535
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:54 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Jansen, Mark
  • Schmidt, A. F.
  • Jans, J. J. M.
  • Christiaans, I.
  • Crabben, S. N. van der
  • Hoedemaekers, Y. M.
  • Dooijes, D.
  • Jongbloed, J. D. H.
  • Boven, L. G.
  • Lekanne Deprez, R. H.
  • Wilde, A. A. M.
  • Velden, J. van der
  • Boer, R. A. de
  • Tintelen, J. P. van
  • Asselbergs, F. W.
  • Baas, A. F.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants

Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants

MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset

MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Hypertrophic Cardiomyopathy with a Twist

Hypertrophic Cardiomyopathy with a Twist

Diagnosis and management of hypertrophic cardiomyopathy

Diagnosis and management of hypertrophic cardiomyopathy

Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study

Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study

Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy

Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy

Non-contrast T1rho CMR for hypertrophic cardiomyopathy

Non-contrast T1rho CMR for hypertrophic cardiomyopathy

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy

Molecular mechanisms of RASopathy-associated hypertrophic cardiomyopathy

Molecular mechanisms of RASopathy-associated hypertrophic cardiomyopathy

FHL2 expression and variants in hypertrophic cardiomyopathy

FHL2 expression and variants in hypertrophic cardiomyopathy

T-tubule remodeling in human hypertrophic cardiomyopathy

T-tubule remodeling in human hypertrophic cardiomyopathy

Verbundene Objekte